sec filing
CO
NASDAQ · COCH
Envoy Medical, Inc.
Healthcare · Medical - Devices
$0.68
Up+$0.03 (+4.95%)
Updated Sep 19, 2026, 1:08 AM
SID Score
3.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 17.26M
- P/E ratio
- -0.75
- Dividend yield
- 0.00%
- 52-week range
- $0.36 – $1.89
- Volume
- 175.2K
- Avg. volume
- 3.01M
Price performance
COCH price history
1M range · 19 trading sessions · Daily adjusted prices
COCH closed at $0.68 after 19 trading sessions, down 9.31% for the selected period.
- Last close
- $0.68
- Period change
- -9.31%
- Period low
- $0.68
- Period high
- $0.75
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 17, 2026 | $0.7314 | $0.7314 | $0.6801 | $0.6802 | 175.2K |
| Sep 16, 2026 | $0.71 | $0.7261 | $0.71 | $0.7101 | 74.39K |
| Sep 15, 2026 | $0.73 | $0.76 | $0.71 | $0.71 | 36.1K |
| Sep 14, 2026 | $0.75 | $0.753 | $0.7275 | $0.7301 | 51.99K |
| Sep 11, 2026 | $0.692 | $0.75 | $0.692 | $0.7402 | 109.76K |
| Sep 10, 2026 | $0.69 | $0.7199 | $0.69 | $0.71 | 17.16K |
| Sep 9, 2026 | $0.691 | $0.71 | $0.69 | $0.6903 | 37.25K |
| Sep 8, 2026 | $0.72 | $0.7295 | $0.71 | $0.7111 | 45.93K |
| Sep 4, 2026 | $0.71 | $0.7301 | $0.7004 | $0.71 | 28.15K |
| Sep 3, 2026 | $0.7199 | $0.7342 | $0.6902 | $0.7301 | 84.62K |
| Sep 2, 2026 | $0.7272 | $0.7272 | $0.682 | $0.689 | 57.53K |
| Sep 1, 2026 | $0.729 | $0.729 | $0.7006 | $0.7044 | 26.7K |
| Aug 31, 2026 | $0.6926 | $0.73 | $0.6926 | $0.729 | 29.35K |
| Aug 28, 2026 | $0.759 | $0.759 | $0.6901 | $0.6901 | 49.04K |
| Aug 27, 2026 | $0.7366 | $0.74 | $0.7151 | $0.7309 | 47.69K |
| Aug 26, 2026 | $0.74 | $0.7579 | $0.7302 | $0.736 | 52.23K |
| Aug 25, 2026 | $0.726 | $0.75 | $0.726 | $0.747 | 48.78K |
| Aug 24, 2026 | $0.7495 | $0.75 | $0.7301 | $0.7462 | 63.76K |
| Aug 21, 2026 | $0.75 | $0.75 | $0.7302 | $0.75 | 60.86K |
Latest COCH news
The latest Smart Investors Daily articles mentioning COCH.
Stock researchResearch & News · SEC Filings
Loading stock research…

